Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03337100 · ClinicalTrials.gov registry record · NA
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03337100 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 7 participants.
The verdict
NCT03337100, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
In the setting of naloxone standing orders, this study will assess if co-dispensing naloxone with opioids to patients prescribed chronic opioid therapy changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about overdose and naloxone.
Interventions
- BEHAVIORAL Co-Dispensing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03337100
The ClinicalTrials.gov registry entry for NCT03337100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Co-Dispensing is the first listed.
NCT03337100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03337100 about?
NCT03337100 is a clinical study titled "The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy". In the setting of naloxone standing orders, this study will assess if co-dispensing naloxone with opioids to patients prescribed chronic opioid therapy changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about overdose and naloxone.
What is the current status of trial NCT03337100?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-11-27. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03337100?
The interventions under investigation include: Co-Dispensing (BEHAVIORAL).
Who is sponsoring clinical trial NCT03337100?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.